Target Name: MIR4292
NCBI ID: G100422860
Other Name(s): hsa-miR-4292 | hsa-mir-4292 | MicroRNA 4292 | microRNA 4292

MIR4292: A Potential Drug Target and Biomarker

MIR4292 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the immune response and has been shown to play a critical role in the regulation of inflammation and autoimmune diseases. In this article, we will explore the biology of MIR4292 and its potential as a drug target and biomarker.

MIR4292: A Non-Coding RNA Molecule

MIR4292 is a non-coding RNA molecule that was identified by bioinformatics analysis of RNA sequencing data. It is composed of 21 amino acid residues and has a calculated molecular weight of 13.9 kDa. MIR4292 is expressed in a variety of tissues and cells, including muscle, pancreas, and immune cells.

MIR4292: Regulation of the Immune Response

MIR4292 has been shown to play a critical role in the regulation of the immune response. It is a key regulator of the development and function of natural killer cells, which are a critical part of the immune system that are responsible for targeting and destroying infected or mutated cells. MIR4292 has been shown to regulate the expression of key immune genes, including IL-2, IL-12, and TGF-β.

MIR4292: Potential Drug Target

MIR4292 has been identified as a potential drug target due to its involvement in the regulation of the immune response. Many diseases, including autoimmune diseases, are characterized by chronic inflammation and impaired immune function. Therefore, targeting MIR4292 with drugs that can modulate its activity could be a promising approach to treating these diseases.

MIR4292: Potential Biomarker

In addition to its role in the immune response, MIR4292 has also been shown to be a potential biomarker for several diseases. For example, MIR4292 has been shown to be downregulated in a variety of cancer types, including breast, ovarian, and colorectal cancers. Therefore, targeting MIR4292 with drugs that can increase its expression could be a promising approach to detecting and treating cancer.

MIR4292: Conclusion

MIR4292 is a non-coding RNA molecule that has been shown to play a critical role in the regulation of the immune response and has the potential to be a drug target and biomarker. Its role in the immune response makes it an attractive target for drugs that can modulate its activity. In addition, its potential as a biomarker for cancer makes it an attractive candidate for drugs that can increase its expression. Further research is needed to fully understand the biology of MIR4292 and its potential as a drug target and biomarker.

Protein Name: MicroRNA 4292

More Common Targets

MIR4293 | MIR4294 | MIR4295 | MIR4296 | MIR4297 | MIR4298 | MIR4299 | MIR4300 | MIR4300HG | MIR4301 | MIR4302 | MIR4303 | MIR4304 | MIR4305 | MIR4306 | MIR4307 | MIR4308 | MIR4309 | MIR431 | MIR4310 | MIR4311 | MIR4312 | MIR4313 | MIR4314 | MIR4315-1 | MIR4315-2 | MIR4316 | MIR4317 | MIR4318 | MIR4319 | MIR432 | MIR4320 | MIR4321 | MIR4322 | MIR4323 | MIR4324 | MIR4325 | MIR4326 | MIR4327 | MIR4328 | MIR4329 | MIR433 | MIR4330 | MIR4418 | MIR4420 | MIR4423 | MIR4425 | MIR4427 | MIR4428 | MIR4429 | MIR4430 | MIR4431 | MIR4432 | MIR4432HG | MIR4433A | MIR4433B | MIR4435-1 | MIR4435-2 | MIR4435-2HG | MIR4436A | MIR4436B1 | MIR4436B2 | MIR4437 | MIR4440 | MIR4441 | MIR4442 | MIR4443 | MIR4444-1 | MIR4444-2 | MIR4445 | MIR4446 | MIR4447 | MIR4448 | MIR4449 | MIR4450 | MIR4451 | MIR4453 | MIR4453HG | MIR4454 | MIR4455 | MIR4456 | MIR4457 | MIR4458 | MIR4458HG | MIR4463 | MIR4465 | MIR4466 | MIR4467 | MIR4468 | MIR4469 | MIR4470 | MIR4472-1 | MIR4472-2 | MIR4474 | MIR4475 | MIR4476 | MIR4478 | MIR4479 | MIR448 | MIR4481